ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

CHRISTOPHER CONLON MD

PMG SAN MATEO 401 SAN MATEO BLVD SE

Albuquerque | New Mexico | 87108

(505) 462-7333

Incorrect Info?
Search this name in Dollars for Docs »

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,148Medicare Part D Prescriptions Filled, Including Refills

Rank: 77 out of 229

$29.4K Total Retail Price of All Prescriptions

Rank: 215 out of 229

512 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 512 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

12% of this provider’s 512 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

3% of this provider’s 5,618 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$5 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

12 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LEVOTHYROXINE SODIUM 255 240 1 1
LISINOPRIL 198 184 2 2
OMEPRAZOLE 189 169 3 4
FUROSEMIDE 174 147 4 8
SIMVASTATIN 171 145 5 3
WARFARIN SODIUM 138 135 6 17
HYDROCODONE-ACETAMINOPHEN 136 126 S3 7 7
OXYBUTYNIN CHLORIDE ER 125 124 8 80
POTASSIUM CHLORIDE 114 92 9 18
DONEPEZIL HCL 114 114 9 29
AMLODIPINE BESYLATE 102 86 11 5
SERTRALINE HCL 97 88 12 22
METOPROLOL SUCCINATE 91 86 13 16
GABAPENTIN 90 64 14 10
METFORMIN HCL 89 88 15 6
CITALOPRAM HBR 86 85 16 21
LOSARTAN POTASSIUM 80 80 17 12
TRAZODONE HCL 80 74 17 34
METOPROLOL TARTRATE 78 77 19 13
HYDROCHLOROTHIAZIDE 78 69 19 9
TAMSULOSIN HCL 76 75 21 24
MELOXICAM 75 71 22 45
LOVASTATIN 63 54 23 11
NAMENDA 62 60 24 39
TRAMADOL HCL 62 62 24 26
RANITIDINE HCL 58 46 26 32
PREDNISONE 58 58 26 35
ALENDRONATE SODIUM 56 56 28 14
FLUTICASONE PROPIONATE 52 45 29 23
FOSINOPRIL SODIUM 52 41 29 184
KETOROLAC TROMETHAMINE 50 46 R 31 308
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 14, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.